Literature DB >> 1598175

Bone mineral and hormone status in paraplegics.

V Finsen1, B Indredavik, K J Fougner.   

Abstract

Nineteen men who had suffered permanent paraplegia a median of 4 years previously were studied. Eight also had varying degrees of neurological deficit of the upper extremities. Bone mineral, biochemical and hormonal values were compared to those in an age-matched control group in order to detect evidence of systemic osteopenia. There were very considerable individual variations in bone mineral density (BMD) deficits among patients compared to controls, probably partly due to methodological problems. Significant BMD deficits were found in the metaphysis (45%) and diaphysis (26%) of the tibia, while the deficit of the distal forearm was barely significant for the group as a whole. There was a negative correlation between time since injury and degree of BMD deficit in the lower extremity. Those with neurological affection of the upper extremities had a greater BMD deficit of their arms than those with neurologically intact arms. It was concluded that osteopenia in paraplegics is largely confined to the paralysed extremities, and thus not systemic. Serum alanine aminotransferase, phosphate, follicle stimulating hormone, and free androgen index (testosterone/sex hormone binding globulin) were mainly within normal limits, but significantly higher in paraplegics than in controls. Osteopenia in these patients is thus not due to gonadal dysfunction.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1598175     DOI: 10.1038/sc.1992.80

Source DB:  PubMed          Journal:  Paraplegia        ISSN: 0031-1758


  17 in total

1.  Assessment of anthropometric, systemic, and lifestyle factors influencing bone status in the legs of spinal cord injured individuals.

Authors:  P Eser; A Frotzler; Y Zehnder; H Schiessl; J Denoth
Journal:  Osteoporos Int       Date:  2004-05-11       Impact factor: 4.507

Review 2.  An evidence-based review of aging of the body systems following spinal cord injury.

Authors:  S L Hitzig; J J Eng; W C Miller; B M Sakakibara
Journal:  Spinal Cord       Date:  2010-12-14       Impact factor: 2.772

Review 3.  Bone loss and muscle atrophy in spinal cord injury: epidemiology, fracture prediction, and rehabilitation strategies.

Authors:  Lora Giangregorio; Neil McCartney
Journal:  J Spinal Cord Med       Date:  2006       Impact factor: 1.985

4.  Spinal cord injury causes more damage to bone mass, bone structure, biomechanical properties and bone metabolism than sciatic neurectomy in young rats.

Authors:  S-D Jiang; L-S Jiang; L-Y Dai
Journal:  Osteoporos Int       Date:  2006-07-28       Impact factor: 4.507

5.  Isolated osteoblasts from spinal cord-injured rats respond less to mechanical loading as compared with those from hindlimb-immobilized rats.

Authors:  Sheng-Dan Jiang; Yue-Hua Yang; Jiang-Wei Chen; Lei-Sheng Jiang
Journal:  J Spinal Cord Med       Date:  2013-05       Impact factor: 1.985

Review 6.  Osteoporosis after spinal cord injury.

Authors:  Sheng-Dan Jiang; Li-Yang Dai; Lei-Sheng Jiang
Journal:  Osteoporos Int       Date:  2005-10-11       Impact factor: 4.507

7.  Longitudinal evaluation of mouse hind limb bone loss after spinal cord injury using novel, in vivo, methodology.

Authors:  Madonna M McManus; Raymond J Grill
Journal:  J Vis Exp       Date:  2011-12-07       Impact factor: 1.355

8.  31st g. Heiner sell lectureship: secondary medical consequences of spinal cord injury.

Authors:  William A Bauman; Mark A Korsten; Miroslav Radulovic; Gregory J Schilero; Jill M Wecht; Ann M Spungen
Journal:  Top Spinal Cord Inj Rehabil       Date:  2012

9.  VA-based survey of osteoporosis management in spinal cord injury.

Authors:  Leslie R Morse; Lora Giangregorio; Ricardo A Battaglino; Robert Holland; B Catharine Craven; Kelly L Stolzmann; Antonio A Lazzari; Sunil Sabharwal; Eric Garshick
Journal:  PM R       Date:  2009-02-06       Impact factor: 2.298

10.  Five-year longitudinal bone evaluations in individuals with chronic complete spinal cord injury.

Authors:  Douglas E Garland; Rodney H Adkins; Charles A Stewart
Journal:  J Spinal Cord Med       Date:  2008       Impact factor: 1.985

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.